Fondren Management’s MGC Diagnostics MGCD Stock Holding History
Bought
Maintained
Sold
Other funds holding MGCD
KPF
Fondren Management's MGCD Position: Q4 2017 in Review
Fondren Management sold out of MGC Diagnostics (MGCD) in Q4 2017, closing a stake of 97,090 shares — an estimated $871K sold.
Fondren Management first reported a position in MGCD in Q4 2016 and held it in 4 quarters. The position peaked at $871K in Q3 2017. 12 funds tracked by Wall St. Rank hold MGCD as of Q4 2017.
- Fondren Management reported no remaining MGC Diagnostics position as of Q4 2017 after selling out during the quarter.
- Fondren Management sold 97,090 MGC Diagnostics shares in Q4 2017, an estimated $871K.
- Fondren Management first reported a position in MGC Diagnostics in Q4 2016 and held it in 4 quarters.
- Fondren Management's MGC Diagnostics position peaked at $871K in Q3 2017.
- 12 funds tracked by Wall St. Rank held MGC Diagnostics as of Q4 2017.
Based on Fondren Management's 13F filing for Q4 2017, filed 14 Feb 2018.